Glenview Capital Management, LLC Teva Pharmaceutical Industries LTD Transaction History
Glenview Capital Management, LLC
- $5.16 Billion
- Q3 2024
A detailed history of Glenview Capital Management, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Glenview Capital Management, LLC holds 8,456,324 shares of TEVA stock, worth $189 Million. This represents 2.95% of its overall portfolio holdings.
Number of Shares
8,456,324
Previous 9,157,641
7.66%
Holding current value
$189 Million
Previous $149 Million
2.4%
% of portfolio
2.95%
Previous 2.93%
Shares
4 transactions
Others Institutions Holding TEVA
# of Institutions
625Shares Held
573MCall Options Held
19.6MPut Options Held
6.77M-
Black Rock Inc. New York, NY43MShares$959 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.2MShares$809 Million35.87% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L334.5MShares$771 Million5.5% of portfolio
-
Menora Mivtachim Holdings Ltd.28.8MShares$644 Million3.32% of portfolio
-
Exor Capital LLP London, X026.5MShares$592 Million14.79% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $24.8B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...